Fulcrum Equity Management Has $554,000 Position in Ingredion Incorporated (NYSE:INGR)

Fulcrum Equity Management lifted its stake in shares of Ingredion Incorporated (NYSE:INGR) by 18.2% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 4,033 shares of the company’s stock after buying an additional 620 shares during the quarter. Fulcrum Equity Management’s holdings in Ingredion were worth $554,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Pacer Advisors Inc. raised its stake in Ingredion by 92.4% during the second quarter. Pacer Advisors Inc. now owns 1,764,012 shares of the company’s stock worth $202,332,000 after acquiring an additional 846,967 shares in the last quarter. Acadian Asset Management LLC boosted its position in Ingredion by 177.8% in the second quarter. Acadian Asset Management LLC now owns 396,743 shares of the company’s stock valued at $45,491,000 after buying an additional 253,949 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Ingredion by 55,219.9% during the third quarter. International Assets Investment Management LLC now owns 174,811 shares of the company’s stock worth $240,240,000 after buying an additional 174,495 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Ingredion by 4.9% during the second quarter. Dimensional Fund Advisors LP now owns 2,685,339 shares of the company’s stock worth $308,009,000 after buying an additional 125,543 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec bought a new position in shares of Ingredion in the 3rd quarter valued at $17,094,000. 85.27% of the stock is owned by institutional investors.

Insider Activity at Ingredion

In related news, CEO James P. Zallie sold 371 shares of the stock in a transaction that occurred on Thursday, October 10th. The stock was sold at an average price of $133.58, for a total value of $49,558.18. Following the transaction, the chief executive officer now owns 52,159 shares of the company’s stock, valued at $6,967,399.22. This represents a 0.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Larry Fernandes sold 4,700 shares of Ingredion stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $153.41, for a total value of $721,027.00. Following the completion of the transaction, the senior vice president now owns 29,034 shares in the company, valued at $4,454,105.94. This represents a 13.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 66,197 shares of company stock worth $9,702,315 over the last ninety days. 1.80% of the stock is owned by corporate insiders.

Ingredion Trading Up 0.4 %

Shares of INGR opened at $144.43 on Thursday. The firm has a market cap of $9.41 billion, a P/E ratio of 14.09, a price-to-earnings-growth ratio of 1.25 and a beta of 0.74. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.69 and a current ratio of 2.67. The business has a 50-day moving average of $141.19 and a 200 day moving average of $130.13. Ingredion Incorporated has a fifty-two week low of $105.74 and a fifty-two week high of $155.44.

Ingredion (NYSE:INGR) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $3.05 earnings per share for the quarter, topping analysts’ consensus estimates of $2.58 by $0.47. Ingredion had a net margin of 9.05% and a return on equity of 17.75%. The firm had revenue of $1.87 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period in the previous year, the business posted $2.33 EPS. The business’s quarterly revenue was down 8.0% on a year-over-year basis. As a group, research analysts forecast that Ingredion Incorporated will post 10.59 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. BMO Capital Markets upped their target price on Ingredion from $128.00 to $147.00 and gave the stock a “market perform” rating in a report on Wednesday, November 6th. Oppenheimer lifted their target price on shares of Ingredion from $147.00 to $178.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 6th. Barclays lifted their price target on shares of Ingredion from $145.00 to $168.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Stephens upgraded Ingredion to a “hold” rating in a report on Monday, December 2nd. Finally, UBS Group lifted their target price on Ingredion from $165.00 to $173.00 and gave the stock a “buy” rating in a report on Friday, November 15th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Ingredion presently has a consensus rating of “Moderate Buy” and a consensus target price of $155.17.

About Ingredion

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.